Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nuo Therapeutics (AURX)
OTHER OTC:AURX
Holding AURX?
Track your performance easily
AURX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.76
Previous CloseN/A
Volume8.36K
Average Volume (3M)4.99K
Market Cap
$69.90M
Enterprise ValueN/A
Total Cash (Recent Filing)$16.00M
Total Debt (Recent Filing)$325.55K
Price to Earnings (P/E)―
Beta-0.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding46,598,404
10 Day Avg. Volume2,107
30 Day Avg. Volume4,992
Standard Deviation1348.25
R-Squared0.00131
Alpha194.89
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)59.88
Price to Cash Flow (P/CF)-35.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nuo Therapeutics News
Ownership Overview
43.40% Insiders
―
Mutual Funds
― Other Institutional Investors
56.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AURX FAQ
What was Nuo Therapeutics’s price range in the past 12 months?
Nuo Therapeutics lowest stock price was $0.25 and its highest was $1.76 in the past 12 months.
What is Nuo Therapeutics’s market cap?
Nuo Therapeutics’s market cap is $69.90M.
When is Nuo Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nuo Therapeutics’s earnings last quarter?
Currently, no data Available
Is Nuo Therapeutics overvalued?
According to Wall Street analysts Nuo Therapeutics’s price is currently Overvalued.
Does Nuo Therapeutics pay dividends?
Nuo Therapeutics does not currently pay dividends.
What is Nuo Therapeutics’s EPS estimate?
Nuo Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuo Therapeutics have?
Nuo Therapeutics has 46,598,404 shares outstanding.
What happened to Nuo Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nuo Therapeutics?
Currently, no hedge funds are holding shares in AURX
---
Company Description
Nuo Therapeutics
Nuo Therapeutics, Inc. engages in developing and marketing products for chronic wound care. It offers Aurix point of care technology for the safe and efficient separation of autologous blood to produce a platelet based therapy for the chronic wound care market. The company was founded on April 29, 1998 and is headquartered in Gaithersburg, MD.
---
Technical Analysis
---